BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kucinskaite-Kodze I, Simanavicius M, Dapkunas J, Pleckaityte M, Zvirbliene A. Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity. Biomolecules 2020;10:E1009. [PMID: 32650398 DOI: 10.3390/biom10071009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Santa-coloma TA. Overlapping synthetic peptides as a tool to map protein-protein interactions ̶ FSH as a model system of nonadditive interactions. Biochimica et Biophysica Acta (BBA) - General Subjects 2022. [DOI: 10.1016/j.bbagen.2022.130153] [Reference Citation Analysis]
2 Rudenko N, Nagel A, Zamyatina A, Karatovskaya A, Salyamov V, Andreeva-Kovalevskaya Z, Siunov A, Kolesnikov A, Shepelyakovskaya A, Boziev K, Melnik B, Brovko F, Solonin A. A Monoclonal Antibody against the C-Terminal Domain of Bacillus cereus Hemolysin II Inhibits HlyII Cytolytic Activity. Toxins (Basel) 2020;12:E806. [PMID: 33352744 DOI: 10.3390/toxins12120806] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Rui D, Yan Z, Xiangzhu X, Yunfeng H, Jing N, Xuming D, Qiu J, Lv Q. Inhibitory effect of hederagenin on Streptococcus pneumoniae pneumolysin in vitro. Microbes Infect 2021;:104888. [PMID: 34547436 DOI: 10.1016/j.micinf.2021.104888] [Reference Citation Analysis]
4 Gingerich AD, Mousa JJ. Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies. Front Cell Infect Microbiol 2022;12:824788. [DOI: 10.3389/fcimb.2022.824788] [Reference Citation Analysis]
5 Widerspick L, Vázquez CA, Niemetz L, Heung M, Olal C, Bencsik A, Henkel C, Pfister A, Brunetti JE, Kucinskaite-kodze I, Lawrence P, Muñoz Fontela C, Diederich S, Escudero-pérez B. Inactivation Methods for Experimental Nipah Virus Infection. Viruses 2022;14:1052. [DOI: 10.3390/v14051052] [Reference Citation Analysis]
6 Ganpule S, Vijaya AK, Sukova A, Preta G. Membrane Cholesterol Content and Lipid Organization Influence Melittin and Pneumolysin Pore-Forming Activity. Toxins 2022;14:346. [DOI: 10.3390/toxins14050346] [Reference Citation Analysis]